Creo Medical (UK) Analysis
| CREO Stock | 16.00 0.13 0.81% |
Creo Medical Group is overvalued with Real Value of 14.88 and Hype Value of 17.17. The main objective of Creo Medical stock analysis is to determine its intrinsic value, which is an estimate of what Creo Medical Group is worth, separate from its market price. There are two main types of Creo Medical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Creo Medical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Creo Medical's stock to identify patterns and trends that may indicate its future price movements.
The Creo Medical stock is traded in UK on London Exchange, with the market opening at 08:00:00 and closing at 16:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in UK. Creo Medical is usually not traded on Summer Bank Holiday, Christmas Day, Boxing Day, New Year 's Day, Good Friday, Easter Monday, May Day Bank Holiday, Spring Bank Holiday ( 2025 ). Creo Stock trading window is adjusted to Europe/London timezone.
Creo |
Creo Stock Analysis Notes
About 20.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.4. Some equities with similar Price to Book (P/B) outperform the market in the long run. Creo Medical Group recorded a loss per share of 0.06. The entity had not issued any dividends in recent years. For more info on Creo Medical Group please contact Craig Gulliford at 44 12 9160 6005 or go to https://www.creomedical.com.Creo Medical Quarterly Total Revenue |
|
Creo Medical Group Investment Alerts
| Creo Medical Group generated a negative expected return over the last 90 days | |
| Creo Medical Group has high historical volatility and very poor performance | |
| Creo Medical Group has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 30.8 M. Net Loss for the year was (21.7 M) with profit before overhead, payroll, taxes, and interest of 11.59 M. | |
| Creo Medical generates negative cash flow from operations | |
| About 20.0% of the company shares are held by company insiders |
Creo Medical Thematic Classifications
In addition to having Creo Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | DrugsDrug manufacturing and delivery |
Creo Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 67.99 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Creo Medical's market, we take the total number of its shares issued and multiply it by Creo Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Creo Profitablity
Creo Medical's profitability indicators refer to fundamental financial ratios that showcase Creo Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Creo Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Creo Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Creo Medical's profitability requires more research than a typical breakdown of Creo Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.74) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.89) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.89. Management Efficiency
Creo Medical Group has return on total asset (ROA) of (0.201) % which means that it has lost $0.201 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3849) %, meaning that it generated substantial loss on money invested by shareholders. Creo Medical's management efficiency ratios could be used to measure how well Creo Medical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Creo Medical's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 40.6 M in 2024, whereas Total Current Assets are likely to drop slightly above 32.9 M in 2024.Leadership effectiveness at Creo Medical Group is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin (0.89) | Profit Margin (0.74) | Beta 0.851 | Return On Assets (0.20) | Return On Equity (0.38) |
Technical Drivers
As of the 28th of November, Creo Medical shows the risk adjusted performance of (0.19), and Mean Deviation of 2.2. Creo Medical Group technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Creo Medical Group mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Creo Medical Group is priced correctly, providing market reflects its regular price of 16.0 per share.Creo Medical Group Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Creo Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Creo Medical Group. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Creo Medical Outstanding Bonds
Creo Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Creo Medical Group uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Creo bonds can be classified according to their maturity, which is the date when Creo Medical Group has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Creo Medical Predictive Daily Indicators
Creo Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Creo Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Creo Medical Forecast Models
Creo Medical's time-series forecasting models are one of many Creo Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Creo Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Creo Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Creo Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Creo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Creo Medical. By using and applying Creo Stock analysis, traders can create a robust methodology for identifying Creo entry and exit points for their positions.
Creo Medical is entity of United Kingdom. It is traded as Stock on LSE exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Creo Medical to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
Additional Tools for Creo Stock Analysis
When running Creo Medical's price analysis, check to measure Creo Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creo Medical is operating at the current time. Most of Creo Medical's value examination focuses on studying past and present price action to predict the probability of Creo Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creo Medical's price. Additionally, you may evaluate how the addition of Creo Medical to your portfolios can decrease your overall portfolio volatility.